Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Conference News TVT 2016

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

Michael O'Riordan

June 20, 2016

News Conference News TVT 2016

Valve Degeneration Data Dearth Spurs Calls for Universal Definitions and Clinical Guidance

Shelley Wood

June 20, 2016

News Conference News TVT 2016

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

Michael O'Riordan

June 18, 2016

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

Presentation TVT 2016

Study Design for the PARTNER 3 Low-Risk Trial

Presenter: Martin B. Leon

June 16, 2016

Presentation TVT 2016

Study Design for the EVOLUT R Low-Risk Trial

Presenter: Jeffrey J. Popma

June 16, 2016

Presentation TVT 2016

The Relentless Journey of TAVR to Lower-Risk Patients: Are We There Yet?

Presenter: Martin B. Leon

June 16, 2016

Presentation TVT 2015

New Indications Coming: The Role of the Heart Team in the Assessment of Intermediate- and Low-Risk Patients

Presenter: Susheel K. Kodali, David A. Wood

June 06, 2015

Presentation TVT 2015

A Surgeons Perspective: Will the IMPLANTING TEAM Change for Intermediate- and Low-Risk Transfemoral TAVR Patients?

Presenter: Francesco Maisano

June 04, 2015

Presentation TVT 2015

Should the Minimalist Approach Change for Intermediate- and Low-Risk TAVR Patients?

Presenter: Vinayak Bapat

June 04, 2015

Presentation TVT 2015

Making the Case for TAVR Expansion to Lower-Risk Patients!

Presenter: Robert O. Bonow, Martin B. Leon, Jean-Michel Paradis, Nicolo Piazza

June 04, 2015

Presentation TVT 2014

CON: A Call to Reason and Restraint

Presenter: Neil E. Moat

June 05, 2014

Presentation TVT 2014

PRO: It has Already Happened and It's Justified

Presenter: Axel Linke

June 05, 2014

Advertisement

Teenage TAVR: Should Practice Forge on While Guidelines Grow Up?

Valve Degeneration Data Dearth Spurs Calls for Universal Definitions and Clinical Guidance

Not All Valves With Leaflet Thickening Develop Mobility Problems, Repeat 4D CT Shows in SAVORY

What TAVR Needs Next . . . and What It’s Getting

Study Design for the PARTNER 3 Low-Risk Trial

Study Design for the EVOLUT R Low-Risk Trial

The Relentless Journey of TAVR to Lower-Risk Patients: Are We There Yet?

New Indications Coming: The Role of the Heart Team in the Assessment of Intermediate- and Low-Risk Patients

A Surgeons Perspective: Will the IMPLANTING TEAM Change for Intermediate- and Low-Risk Transfemoral TAVR Patients?

Should the Minimalist Approach Change for Intermediate- and Low-Risk TAVR Patients?

Making the Case for TAVR Expansion to Lower-Risk Patients!

CON: A Call to Reason and Restraint

PRO: It has Already Happened and It's Justified

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content